CJC/IPA – 5/5mg
£29.00
Availability: 7 in stock
CJC-1295 (no DAC) 5mg + Ipamorelin 5mg: product identification
- Catalog reference: cj-5-a11
- Quantity: 5mg/5mg
- Form: Lyophilised powder
- Reference compound (ipamorelin component): Ipamorelin; PubChem CID 9831659
- Reference CAS number: 170851-70-4
- Reference molecular formula: C38H49N9O5
- Reference molecular weight: 711.9 g/mol
- Reference sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Purity: See batch certificate of analysis
Reference identifiers come from PubChem and describe the reference compound. They do not establish the salt form or specification of an individual batch; consult that batch’s certificate of analysis.
Research background
Ipamorelin is a synthetic pentapeptide first described in 1998 as a selective growth hormone secretagogue; the original paper characterised GH release in vitro and in vivo in animal models (Raun et al., Eur J Endocrinol 1998). The CJC-1295 (no DAC) component is identified on each batch certificate of analysis.
Quality and documentation
Every ETHOS batch is 8X tested, meaning eight different tests, before it ships. Batch COAs are published and searchable by lot number in the ETHOS public COA portal; see also our ETHOS UK COA page and the guide how to read a peptide certificate of analysis.
Storage and handling
Store sealed at −20 °C, protected from light and moisture. Handle in a laboratory setting by qualified personnel. Research use only.
Disclaimer
For laboratory research use only. Not for human or veterinary use. Not for consumption, diagnostic or therapeutic use of any kind. All information is provided for identification and handling purposes and is not a claim of any effect.
